Back to Search Start Over

Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma

Authors :
Jiayu Liang
Guangxi Sun
Xiuyi Pan
Mengni Zhang
Pengfei Shen
Sha Zhu
Jinge Zhao
Linmao Zheng
Junjie Zhao
Yuntian Chen
Xiaoxue Yin
Junru Chen
Xu Hu
Yuhao Zeng
Jianhui Chen
Yongquan Wang
Zhihong Liu
Jin Yao
Minggang Su
Rui Huang
Banghua Liao
Qiang Wei
Xiang Li
Qiao Zhou
Jiyan Liu
Yali Shen
Zhenhua Liu
Ni Chen
Hao Zeng
Xingming Zhang
Source :
Genome Medicine, Vol 15, Iss 1, Pp 1-18 (2023)
Publication Year :
2023
Publisher :
BMC, 2023.

Abstract

Abstract Background Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare highly aggressive subtype of kidney cancer for which the distinct genomic, transcriptomic, and evolutionary relationships between metastatic and primary lesions are still unclear. Methods In this study, whole-exome, RNA-seq, and DNA methylation sequencing were performed on primary-metastatic paired specimens from 19 FH-RCC cases, including 23 primary and 35 matched metastatic lesions. Phylogenetic and clonal evolutionary analyses were used to investigate the evolutionary characteristics of FH-RCC. Transcriptomic analyses, immunohistochemistry, and multiple immunofluorescence experiments were performed to identify the tumor microenvironmental features of metastatic lesions. Results Paired primary and metastatic lesions generally showed similar characteristics of tumor mutation burden, tumor neoantigen burden, microsatellite instability score, CNV burden, and genome instability index. Notably, we identified an FH-mutated founding MRCA (the most recent common ancestor) clone that dominated the early evolutionary trajectories in FH-RCC. Although both primary and metastatic lesions manifested high immunogenicity, metastatic lesions exhibited higher enrichment of T effector cells and immune-related chemokines, together with upregulation of PD-L1, TIGIT, and BTLA. In addition, we found that concurrent NF2 mutation may be associated with bone metastasis and upregulation of cell cycle signature in metastatic lesions. Furthermore, although in FH-RCC metastatic lesions in general shared similar CpG island methylator phenotype with primary lesions, we found metastatic lesions displaying hypomethylated chemokine and immune checkpoints related genomic loci. Conclusions Overall, our study demonstrated the genomic, epigenomic, and transcriptomic features of metastatic lesions in FH-RCC and revealed their early evolutionary trajectory. These results provided multi-omics evidence portraying the progression of FH-RCC.

Details

Language :
English
ISSN :
1756994X
Volume :
15
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Genome Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.6c8795d0b02740948debb30b7bd00337
Document Type :
article
Full Text :
https://doi.org/10.1186/s13073-023-01182-7